<title>Vertex Pharmaceuticals (VRTX) News & Commentary

DJIA

15,387.58

52.30

0.34%

NASDAQ

3,502.12

5.69

0.16%

S&P 500

1,669.16

2.87

0.17%

5/20/2013 by YCharts

5/20/2013 by TheStreet

5/17/2013 by DailyFinance

5/16/2013 by TheStreet

5/15/2013 by TheStreet

The yields look great, but these 2 health-care dividend stocks could be the scariest ones around in the near future.

5/15/2013 by DailyFinance

Johnson & Johnson jumps ahead of Gilead Sciences in the race to bring next-generation hepatitis C drugs to market.

5/14/2013 by DailyFinance

Can you develop an investment strategy based on a biotech success story? Here are 3 lessons that show how it can be done.

5/11/2013 by DailyFinance

5/9/2013 by DailyFinance

5/9/2013 by Seeking Alpha